- Home
- BOBS vs PGNY Comparison
BOBS vs PGNY Comparison
Compare BOBS & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$20.15
HOLD
Current Price
$20.77
Company Overview
Basic Information| Metric | BOBS | PGNY |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2026 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BOBS | PGNY |
|---|---|---|
| Price | $20.15 | $20.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $27.90 |
| AVG Volume (30 Days) | ★ 3.7M | 1.4M |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.96 |
| EPS | ★ 1.06 | 0.62 |
| Revenue | ★ $2,318,973,000.00 | $1,268,689,000.00 |
| Revenue This Year | N/A | $11.63 |
| Revenue Next Year | N/A | $9.52 |
| P/E Ratio | ★ $18.86 | $33.52 |
| Revenue Growth | 1.00 | ★ 11.41 |
| 52 Week Low | $16.47 | $17.98 |
| 52 Week High | $20.65 | $28.75 |
Technical Indicators
Market Signals| Indicator | BOBS | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 26.78 |
| Support Level | N/A | $20.75 |
| Resistance Level | N/A | $21.75 |
| Average True Range (ATR) | 0.00 | 0.89 |
| MACD | 0.00 | -0.29 |
| Stochastic Oscillator | 0.00 | 1.90 |
Price Performance
Historical Comparison BOBS
PGNY
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.